Company / Shareholders' Equity
Whitehawk Therapeutics, Inc. Shareholders' Equity History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$52.5M
FY2025
5-year range
-$12.4M / $158.4M
FY2021-FY2025
Trend
-50.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 8 years, ranging from -$12M in FY2021 to $158M in FY2023.
Based on SEC 10-K filings.
$52M in FY2025 with a 5-year CAGR of +7.5%.
Declined from $158M to $52M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -27.3%
- 5-Year CAGR
- +7.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +7.5%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 50.1% year-over-year.
- Peak shareholders' equity was recorded in FY2023.
- Lowest shareholders' equity in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $52.5M | -50.1% |
| FY2024 | $105.2M | -33.6% |
| FY2023 | $158.4M | +16.1% |
| FY2022 | $136.4M | +1197.2% |
| FY2021 | -$12.4M | -134.0% |
| FY2020 | $36.5M | -37.7% |
| FY2019 | $58.7M | +236.5% |
| FY2018 | $17.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026